| P2093 | author name string | J. O. McNamara | |
| | J. E. Kraus | |
| P2860 | cites work | periodic paralysis | Q1788314 |
| | Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene | Q41135926 |
| | Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site | Q41354036 |
| | Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation | Q41491359 |
| | Functional expression of sodium channel mutations identified in families with periodic paralysis | Q41576682 |
| | Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia | Q46473803 |
| | Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins | Q46739659 |
| | NMDA-dependent superoxide production and neurotoxicity | Q48234286 |
| | The role of nitric oxide in hippocampal long-term potentiation | Q48542124 |
| | Possible involvement of nitric oxide in long-term potentiation | Q48690459 |
| | Strychnine-sensitive inhibition in the medullary reticular formation: evidence for glycine as an inhibitory transmitter | Q48765041 |
| | Ion channel shake-down. | Q52536402 |
| | Did radicals strike Lou Gehrig? | Q59073020 |
| | Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite | Q67568058 |
| | A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivation | Q67915164 |
| | Membrane defects in paramyotonia congenita (Eulenburg) | Q69406285 |
| | Structure and function of voltage-gated ion channels | Q71612070 |
| | Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families | Q72017458 |
| | Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis | Q72621641 |
| | Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis | Q72663413 |
| | Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1 | Q24312199 |
| | Identification of a mutation in the gene causing hyperkalemic periodic paralysis | Q24314688 |
| | A missense mutation in the gene encoding the alpha 1 subunit of the inhibitory glycine receptor in the spasmodic mouse | Q24321378 |
| | Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia | Q24336984 |
| | Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels | Q24531491 |
| | Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger | Q24559960 |
| | Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase | Q27731976 |
| | Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 |
| | Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis | Q28183046 |
| | Temperature-sensitive mutations in the III–IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita | Q28208914 |
| | Primary structure of the adult human skeletal muscle voltage‐dependent sodium channel | Q28210170 |
| | Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita | Q28210343 |
| | A calcium channel mutation causing hypokalemic periodic paralysis | Q28242375 |
| | Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene | Q28242463 |
| | Dihydropyridine receptor mutations cause hypokalemic periodic paralysis | Q28243593 |
| | Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis | Q28245345 |
| | Hypokalemic periodic paralysis: In vitro investigation of muscle fiber membrane parameters | Q28265960 |
| | A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis | Q28305953 |
| | Glycine receptor alteration in the mutant mouse spastic | Q28505662 |
| | Isoform-selective deficit of glycine receptors in the mouse mutant spastic | Q28589353 |
| | Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation | Q29547561 |
| | Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q | Q30541673 |
| | Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase | Q30994005 |
| | Biochemistry of Nitric Oxide and Its Redox-Activated Forms | Q35159350 |
| | Analysis in a large hyperkalemic periodic paralysis pedigree supports tight linkage to a sodium channel locus | Q35197093 |
| | Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity | Q35693516 |
| | Nitric oxide and synaptic function | Q40389935 |
| | Nitric oxide: a physiologic messenger molecule | Q40394921 |
| | Overexcited or inactive: ion channels in muscle disease | Q40398641 |
| | Oxidative stress, glutamate, and neurodegenerative disorders | Q40618533 |
| | Excitotoxicity, free radicals, and cell membrane changes | Q40753471 |
| | Duchenne-Becker muscular dystrophy and the nondystrophic myotonias. Paradigms for loss of function and change of function of gene products | Q40769399 |
| | Genotype-phenotype correlations in human skeletal muscle sodium channel diseases | Q40769409 |
| | The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins | Q41074853 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 358-366 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Current Opinion in Neurobiology | Q15763572 |
| P1476 | title | Clinical relevance of defects in signalling pathways | |
| P478 | volume | 5 | |